Health Catalyst ( (HCAT) ) has released its Q1 earnings. Here is a breakdown of the information Health Catalyst presented to its investors.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Health Catalyst is a prominent provider of data and analytics technology and services aimed at enhancing healthcare outcomes, serving over 1,000 organizations globally with its cloud-based solutions and expert services.
In its first quarter of 2025 earnings report, Health Catalyst announced a total revenue of $79.4 million and an Adjusted EBITDA of $6.3 million, surpassing its quarterly guidance. The company also reported the addition of 10 new platform clients, a positive sign towards achieving its annual target of 40 new clients.
The financial highlights for the quarter show a 6% increase in total revenue compared to the previous year, although the company experienced a 15% increase in net loss, amounting to $23.7 million. The Adjusted EBITDA saw a significant rise of 86% year-over-year, reflecting improved operational efficiencies. Despite a decrease in gross profit and margin, the company managed to maintain a steady adjusted gross margin of 49%.
Looking ahead, Health Catalyst projects a total revenue of approximately $80.5 million and an Adjusted EBITDA of around $8 million for the second quarter of 2025. For the full year, the company anticipates reaching a total revenue of $335 million and an Adjusted EBITDA of $41 million, indicating a positive outlook for continued growth and client acquisition.